Abstract: A bit interleaver, a bit-interleaved coded modulation (BICM) device and a bit interleaving method are disclosed herein. The bit interleaver includes a first memory, a processor, and a second memory. The first memory stores a low-density parity check (LDPC) codeword having a length of 64800 and a code rate of 7/15. The processor generates an interleaved codeword by interleaving the LDPC codeword on a bit group basis. The size of the bit group corresponds to a parallel factor of the LDPC codeword. The second memory provides the interleaved codeword to a modulator for quadrature phase shift keying (QPSK) modulation.

Abstract: A positive electrode active material particle includes a core that contains lithium cobalt oxide represented by the following Chemical Formula LiaCo(1-x)MxO2-yAy and a shell that is coated on the surface of the core and contains composite metal oxide of a metal with an oxidation number of +2 and a metal with an oxidation number of +3. In particular, M is at least one selected from the group consisting of Ti, Mg, Zn, Si, Al, Zr, V, Mn, Nb and Ni. A is oxygen-substitutional halogen and 1.00?a?1.05, 0?x?0.05, and 0?y?0.001.

Abstract: An apparatus and method for multiplexing signals using layered division multiplexing are disclosed. A signal multiplexing apparatus according to an embodiment of the present invention includes a combiner configured to combine a core layer signal and an enhanced layer signal at different power levels, and a time interleaver configured to perform interleaving applied to both the core layer signal and the enhanced layer signal.

Abstract: A bit interleaver, a bit-interleaved coded modulation (BICM) device and a bit interleaving method are disclosed herein. The bit interleaver includes a first memory, a processor, and a second memory. The first memory stores a low-density parity check (LDPC) codeword having a length of 64800 and a code rate of 7/15. The processor generates an interleaved codeword by interleaving the LDPC codeword on a bit group basis. The size of the bit group corresponds to a parallel factor of the LDPC codeword. The second memory provides the interleaved codeword to a modulator for quadrature phase shift keying (QPSK) modulation.

Abstract: An aspect of the present disclosure discloses a method for diagnosing a network performance in an apparatus for diagnosing network performance connected to a switching device provided between a first entity and a second entity. The method may include: obtaining at least one mirrored packet for at least one packet transmitted between the first entity and the second entity based on mirroring from the switching device, calculating performance related indicator representing performance of a network service associated with the first entity and the second entity based on at least a part of information included in the at least one mirrored packet, and storing the calculated performance related indicators.

Abstract: The present invention relates to a binaural beat sound output device having an improved sound field and a method therefor and, more specifically, to: a brainwave sound output device using binaural beats, which receives music desired by a user and applies binaural beats to a specific frequency band thereof, so that the device can provide the music through a stereo sound source while inducing a desired brainwave state by the stereo sound source, and thus can improve the sound field without the sense of rejection or monotony to the music; and a method therefor.

Abstract: The present invention relates to a composition for diagnosing or treating kidney disease, and specifically, provides a composition for diagnosing kidney disease, including VSIG4 or a gene coding same as an active ingredient, and a pharmaceutical composition for preventing or treating kidney disease, including an expression or activity inhibitor for VSIG4 or a gene coding same as an active ingredient.

Abstract: Disclosed are a method of manufacturing a flame-retardant rayon staple fiber, and a flame-retardant rayon staple fiber laminate made from the same staple fiber. The method includes a step of impregnating a flame-retardant staple fiber web with a flame-retardant solution in which a starch and an inorganic powder are mixed and a step of drying the impregnated staple fiber web. When the flame-retardant rayon staple fiber is manufactured by the method, inorganic particles absorbed by the staple fiber do not easily detach, thereby improving flame retardancy of the fiber. When a staple fiber laminate is made from the staple fiber manufactured by the method, the strength of the laminate is improved due to the presence of the starch, and the workability and moldability of the laminate are also improved due to the increased strength.

Abstract: A method of generating excision tool information using a cervicography image includes receiving, by an analysis apparatus, a cervicography image of a patient, inputting, by the analysis apparatus, the cervicography image to a learning model to detect a lesion area, additionally setting, by the analysis apparatus, a margin area based on the lesion area to determine an excision area, and selecting, by the analysis apparatus, one excision tool according to a shape and size of the excision area, or generating a source model for manufacturing an excision tool based on the shape and size of the excision area.

Abstract: The present invention relates to the use of a 2,3,5-substituted thiophene compound for the prevention, amelioration or treatment of gastrointestinal stromal tumor. The 2,3,5-substituted thiophene compound exhibits high inhibitory activity against the growth of gastrointestinal stromal tumor, and thus may be effectively used for the prevention, amelioration or treatment of gastrointestinal stromal tumor.

Abstract: The present invention relates to the use of a 2,3,5-substituted thiophene compound for the prevention, amelioration or treatment of mastocytosis. The 2,3,5-substituted thiophene compound has excellent inhibitory activity against the growth of mastocytosis cells and against an inflammatory response caused by mastocytosis, and thus may be effectively used for the prevention, amelioration or treatment of mastocytosis.

Abstract: The present invention relates to a pyrido[[3,4-d]pyrimidine derivative compound showing excellent anti-proliferative efficacy against cancer cells, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a stereoisomer thereof, a production method therefor, a pharmaceutical composition for preventing, alleviating, or treating cancer metastasis and proliferative diseases containing the same as an active ingredient, and an anticancer composition for cancer cells. The compound exhibits excellent inhibitory activity and anti-proliferative efficacy against cancer cells, and thus the compound is useful not only for inhibiting cancer cells, but also for preventing cancer metastasis and proliferative diseases or for treating cancer.

Abstract: The present disclosure relates to a 7-amino-3,4-dihydropyrimidopyrimidin-2-one derivative compound exhibiting excellent anti-proliferative effects against cancer cells, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a stereoisomer thereof, a production method therefor, a pharmaceutical composition for preventing, alleviating or treating cancer metastasis and proliferative disease containing the same as an active ingredient, and an anti-cancer composition against cancer cells. The compound exhibits excellent cancer cell inhibitory activity and anti-proliferative effects, and thus is effective in inhibiting cancer cells, preventing cancer metastasis and proliferative diseases or treating cancer.

Abstract: The present invention relates to: a compound selected from among a novel pyridinyltriazine derivative having protein kinase inhibitory activity, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a stereoisomer thereof; a method for preparing the compound; and a pharmaceutical composition which is for preventing, alleviating, or treating cancer and comprises the compound. A novel compound according to the present invention exhibits excellent inhibitory effects against FGFR, which is a major trigger of bladder cancer, endometrial cancer, etc., point mutations thereof, and various protein kinases other than FGFR involved in signal transduction, and is thus effective as an agent for preventing and treating abnormal cell growth diseases caused by such protein kinases.

Abstract: A plasma processing apparatus includes a substrate chuck having a first surface for supporting a substrate, a second surface opposite to the first surface, and a sidewall, a focus ring for surrounding a perimeter of the substrate, and an edge block for supporting the focus ring. The edge block includes a side electrode on the sidewall of the substrate chuck and a bottom electrode on the second surface of the substrate chuck.

Abstract: A method for learning an insurance claim statement on a basis of a deep neural network, includes: receiving, by an insurance claim statement reviewing device, an input of a plurality of insurance review claim statements containing at least one of first information, second information, third information and fourth information; classifying, by the insurance claim statement reviewing device, the general items, the diagnosed patient injury/disease items, the treatment history items, or the prescription items; converting, by the insurance claim statement reviewing device, the categorical data or the numerical data; inputting, by the insurance claim statement reviewing device, the converted data; training, by the insurance claim statement reviewing device, the deep neural network using training data of the converted data; and verifying, by the insurance claim statement reviewing device, the deep neural network using verification data of the converted data.

Abstract: This disclosure relates to a system and a method for automated recognition of drugs. This disclosure also relates to a system for automated recognition of drugs comprising a hyper-spectral imaging system. This disclosure also relates to a hyper-spectral imaging system configured to automatically recognize drugs by using a neural network. This disclosure relates to training the neural network to identify a drug type (e.g., the name of the drug) based on an image (e.g., normal visible image and/or hyperspectral image) of the drug.

Abstract: An aspect of the present disclosure discloses a method for diagnosing a network performance in an apparatus for diagnosing network performance connected to a switching device provided between a first entity and a second entity. The method may include: obtaining at least one mirrored packet for at least one packet transmitted between the first entity and the second entity based on mirroring from the switching device, calculating performance related indicator representing performance of a network service associated with the first entity and the second entity based on at least a part of information included in the at least one mirrored packet, and storing the calculated performance related indicators.

Abstract: The present invention relates to a strain having liver function improving activity, and a use thereof. Specifically, the present invention relates to a health food composition for improving liver function and a pharmaceutical composition for improving liver function, which contain, as an active ingredient, one or more strains selected from the group consisting of a Lactobacillus pentosus KF8 (accession number KCCM11997P) strain, a Bacillus subtilis KF11 (accession number KCCM11981P) strain, and a Lactococcus lactis KF140 (accession number KCCM11673P) strain, a lysate thereof or a culture product thereof.